Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

A male catheter is the Danish medtech company’s biggest launch in half a decade – and CFO Anders Lonning-Skovgaard expects the 12-month rollout to be nothing but smooth sailing.

For subscribers

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix

Another hurdle overcome in delaying MDR deadline

For subscribers

Coloplast launches male catheter featuring new technology

For subscribers

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules

For subscribers

EU Commission to give more time for MDR transition

For subscribers

Coloplast's products generating 80% of revenue have been MDR approved
For six years, the Danish medtech company has been increasing its number of employees tasked with ensuring products comply with new EU regulation – but there’s still a ways to go.
For subscribers
Coloplast agrees to million-dollar settlement in the US
Following its own report of possible violations in connection with sales to US military veterans, the Danish medical technology company agrees to million-dollar settle claims.
For subscribers
Unilabs and Siemens Healthineers enter million-euro strategic partnership
The diagnostic services provider is buying Siemens Healthineers-developed equipment valued at EUR 200m.
For subscribers
Analyst: China headwinds will dampen Coloplast's first quarter
Covid-19 shutdowns in China have restricted patients’ hospital access, which Danish bank Sydbank says will hurt revenue inflows for the Danish medtech company.
For subscribers
Boston Scientific's endoscope sales beat predictions
The US-based medtech firm’s outlook for 2023 is a tad less optimistic than what analysts had hoped for.
For subscribers
Medtrace wins US patent on new heart imaging method
A new patented software developed by the diagnostics firm is one part of a ”unique way of modelling the human heart” – a ”milestone” for Medtrace, though it’s unclear on when the system is marketable.
For subscribers
US medtech group expands production in Denmark
In just a few years, Phillips-Medisize has doubled its staffing, and is now expanding its production facility in Danish town Struer to keep up with demand.
For subscribers
Coloplast is the world's most sustainable medtech firm in new analysis
Among 87 of the largest, publicly listed medtech companies, Coloplast has been deemed the very best on sustainability, according to a new international ranking.
For subscribers
Ambu silent on Russian exit issues
In December, Ambu CEO Britt Meelby Jensen briefly noted that shutting down Russian activities was not going according to plan – and she does not want to say more than that today.
For subscribers
Danish medtech firm partners with German giant to eliminate needles in blood sugar testing
RSP Systems wants to offer a needle-free way for diabetics to monitor their glucose levels, and a billion-dollar German corporation is ready to help them reach the goal.
For subscribers
Renewed optimism could be behind Ambu trading surge, says analyst
So far in 2023, the medtech company’s shares have gone up 20% on the exchange. A Sydbank analyst points to a number of factors for why.
For subscribers
Bionic pancreas system nears commercial launch
The biotech company, a partner of Novo Nordisk and Zealand Pharma, among others, hires a chief medical officer ahead of a commercial launch of the bionic pancreas system.
For subscribers
Inflation has medtech industry in tight squeeze
High inflation is putting pressure on medtech companies that operate in an industry characterized by fixed product prices under year-long contracts. An uncertain year is ahead, reflected in the companies’ financial expectations.
For subscribers
Novo Holdings invests in Danish medtech firm
The Novo Nordisk owner is stepping into the ownership circle of Evosep with an investment that will facilitate the company’s US market entry.
For subscribers
Analyst: Better conditions in China to ease Coloplast's cost pressure
Coloplast has been intensely focused on costs as of late, but Danske Bank now thinks a Chinese relaxation of pandemic restrictions will dispel the worst concerns.
For subscribers
Pandemic made Mexico plant more desirable, says Ambu CEO
In an increasingly uncertain world, having production closer to one’s most important market is just one of the many advantages of the factory in Mexico, says Britt Meelby Jensen, CEO of Ambu.
For subscribers
JPMorgan spots challenging first quarter for European medtech firms
Several medtech companies in Europe have been given the ”underweight” recommendation by JPMorgan.
For subscribers
Operating costs and development in China key focal points for Coloplast in 2023
Energy costs as well as prices on raw materials are among focal points for Coloplast in 2023, while the medical technology company also pivots on ongoing developments in China.
Coloplast chair profits millions of kroner from share options
This week, Lars Rasmussen, Coloplast chair, bought a batch of Coloplast shares exercising his options, and sold them soon after at million-kroner plus.
For subscribers
Olympus to acquire AI endoscopy startup
For around USD 79m, Odin Vision and its cloud-AI platform for endoscopy procedures will come into the fold of Japanese endoscopy giant Olympus.
For subscribers

Latest news

See all

Jobs

See all jobs

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

Another hurdle overcome in delaying MDR deadline

Coloplast launches male catheter featuring new technology

Coloplast's bottom line disappoints in otherwise strong report

Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules

EU Commission to give more time for MDR transition

Coloplast's products generating 80% of revenue have been MDR approved

Coloplast agrees to million-dollar settlement in the US

Unilabs and Siemens Healthineers enter million-euro strategic partnership

Analyst: China headwinds will dampen Coloplast's first quarter

Boston Scientific's endoscope sales beat predictions

Medtrace wins US patent on new heart imaging method

US medtech group expands production in Denmark

Coloplast is the world's most sustainable medtech firm in new analysis

Ambu silent on Russian exit issues

Danish medtech firm partners with German giant to eliminate needles in blood sugar testing

Renewed optimism could be behind Ambu trading surge, says analyst

Bionic pancreas system nears commercial launch

Inflation has medtech industry in tight squeeze

Novo Holdings invests in Danish medtech firm

Analyst: Better conditions in China to ease Coloplast's cost pressure

Pandemic made Mexico plant more desirable, says Ambu CEO

JPMorgan spots challenging first quarter for European medtech firms

Operating costs and development in China key focal points for Coloplast in 2023

Coloplast chair profits millions of kroner from share options

Olympus to acquire AI endoscopy startup

Latest news

Jobs